Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2013
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease
Evangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, et al.
Blood
|
December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy
Christian Straka, Michael Sandherr, Hans Salwender, et al.
Blood
|
February 5, 2011
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, et al.
British Journal of Haematology
|
April 7, 2017
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study
Orhan Sezer, Meral Beksac, Roman Hajek, et al.
Blood
|
February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Haematologica
|
October 4, 2015
European Myeloma Network guidelines for the management of multiple myeloma-related complications
Evangelos Terpos, Martina Kleber, Monika Engelhardt, et al.
Leukemia
|
October 3, 2009
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R Fonseca, P L Bergsagel, J Drach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
Meletios A Dimopoulos, Evangelos Terpos, Asher Chanan-Khan, et al.
Blood
|
June 30, 2009
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Shaji Kumar, Sergio Giralt, Edward A Stadtmauer, et al.
Blood
|
August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2013
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease
Evangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, et al.
Blood
|
December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy
Christian Straka, Michael Sandherr, Hans Salwender, et al.
Blood
|
February 5, 2011
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, et al.
British Journal of Haematology
|
April 7, 2017
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study
Orhan Sezer, Meral Beksac, Roman Hajek, et al.
Blood
|
February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Haematologica
|
October 4, 2015
European Myeloma Network guidelines for the management of multiple myeloma-related complications
Evangelos Terpos, Martina Kleber, Monika Engelhardt, et al.
Leukemia
|
October 3, 2009
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R Fonseca, P L Bergsagel, J Drach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2010
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group
Meletios A Dimopoulos, Evangelos Terpos, Asher Chanan-Khan, et al.
Blood
|
June 30, 2009
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Shaji Kumar, Sergio Giralt, Edward A Stadtmauer, et al.
Blood
|
August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.
Page
of 11